Vir Biotechnology (VIR) Other financing activities (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Other financing activities data on file, last reported at $174000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 70.9% year-over-year to $174000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 103.34% YoY), and the FY2025 full-year result was $2.8 million, up 254.05% from the prior year.
• Other financing activities declined to $174000.0 in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $3.6 million in Q3 2022 to a low of -$2.9 million in Q4 2023.
• A 5-year average of $471058.8 and a median of $598000.0 in 2025 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 377.27% in 2023, while the deepest fall reached 410.3% in 2023.
• Tracing VIR's Other financing activities over 5 years: stood at $932000.0 in 2022, then slumped by 410.3% to -$2.9 million in 2023, then soared by 133.47% to $968000.0 in 2024, then jumped by 49.69% to $1.4 million in 2025, then tumbled by 87.99% to $174000.0 in 2026.
• Business Quant data shows VIR's Other financing activities at $174000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.7 million in Q3 2025.